Page last updated: 2024-08-23

idarubicin and Retinoblastoma

idarubicin has been researched along with Retinoblastoma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alcalde-Ruiz, E; Catala-Mora, J; Chantada, GL; Croxatto, JO; Dabezies, AP; de Dávila, MTG; Dufort, G; Fandiño, AC; Kopp, K; López, JP; Ossandon, D; Parareda-Salles, A; Pérez, V; Ravindranath, Y; Reaman, G; Rey, G; Sampor, C; Suñol, M; Urbieta, M; Zelter, M1
Castañon, A; Chantada, G; Sampor, C; Schaiquevich, P; Winter, U; Zugbi, S1
Azad, R; Chawla, B; Hasan, F; Pathy, S; Pattebahadur, R; Seth, R; Sharma, S; Upadhyaya, A1
Casak, S; Chantada, G; Dávila, MT; Fandiño, A; Manzitti, J; Raslawski, E; Schvartzman, E1
Antoneli, CB; Arias, VE; Chojniak, MM; Novaes, PE; Ribeiro, Kde C; Sakamoto, LH1
Casak, S; Chantada, GL; Fandiño, A; Mato, G1

Reviews

1 review(s) available for idarubicin and Retinoblastoma

ArticleYear
Trilateral retinoblastoma.
    Pediatric blood & cancer, 2007, Volume: 48, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Female; Humans; Idarubicin; Ifosfamide; Male; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neoplastic Syndromes, Hereditary; Pinealoma; Prognosis; Retinoblastoma; Vincristine

2007

Trials

3 trial(s) available for idarubicin and Retinoblastoma

ArticleYear
Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
    Ophthalmology, 2016, Volume: 123, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Eye Enucleation; Female; Humans; Idarubicin; Infant; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Survival Analysis; Vincristine

2016
Results of a prospective study for the treatment of retinoblastoma.
    Cancer, 2004, Feb-15, Volume: 100, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Humans; Idarubicin; Infant; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Optic Nerve Neoplasms; Prospective Studies; Retinoblastoma; Risk Factors; Scleral Diseases; Survival Analysis; Treatment Outcome; Vincristine

2004
Phase II window of idarubicin in children with extraocular retinoblastoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:6

    Topics: Antibiotics, Antineoplastic; Bone Marrow Neoplasms; Bone Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Infant; Lymphatic Metastasis; Male; Neoplasms, Multiple Primary; Orbital Neoplasms; Retinoblastoma; Treatment Outcome

1999

Other Studies

2 other study(ies) available for idarubicin and Retinoblastoma

ArticleYear
Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
    JAMA ophthalmology, 2018, 07-01, Volume: 136, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Humans; Hydrophthalmos; Idarubicin; Infant; Male; Mesna; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Survival Rate; Vincristine

2018
Comparison of the pharmacological activity of idarubicin and doxorubicin for retinoblastoma.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:1

    Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Proliferation; Doxorubicin; Humans; Idarubicin; Retinal Neoplasms; Retinoblastoma; Tumor Cells, Cultured

2019